Articles > Health magazines > Medical magazines > Climacteric articles > October 2007

Article: Metabolic syndrome in postmenopausal women: higher prevalence in the Northeastern Region of Brazil than in other Latin American countries and the influence of obesity and socioeconomic factors/Author's reply

Article from:
Climacteric
Article date:
October 1, 2007
Author:
Copyright

We read with great interest the recent manuscript, by the Collaborative Group for Research of the Climacteric in Latin America, on the prevalence of metabolic syndrome (METS) and its components in postmenopausal Latin American women1. The authors analyzed the prevalence of METS according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP)2 in a total of 3965 postmenopausal women, aged 45-64 years, and observed a high prevalence of METS, ranging from 28.1% in women aged 40-44 years to 42.9% in those aged 60-64 years.

This is an extremely relevant topic in the current clinical management of climacteric, since coronary heart disease (CHD) is the leading cause of ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Association of insulin sensitivity and muscle strength in ...
Applied Physiology, Nutrition, and Metabolism;  April 1, 2007 ;     700+ words ... ... and obese sedentary postmenopausal women. The design of the ... and obese sedentary postmenopausal women (age: 58.2 ... and obese sedentary postmenopausal women. Key words: Insulin ... metabolic syndrome (MetS), which is a cluster ...

Article: The effects of hormone replacement therapy on cardiovascular ...
Cardiopulmonary Physical Therapy Journal;  January 1, 1999 ;     700+ words ... ... cardiovascular disease (CVD) in postmenopausal women. Discussion of the various mechanisms ... responsible for the development of CVD in postmenopausal women is included. Such mechanisms include ... therapy, cardiovascular disease, postmenopausal women, hormone replacement therapy ...

Health issues in postmenopausal women who drink.
Alcohol Research & Health;  December 22, 2002 ;     700+ words ... ... these three diseases in postmenopausal women. The authors stress ... potential health effects in postmenopausal women should be interpreted ... and well. being of postmenopausal women through the direct ...

Article: FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) ...
PR Newswire;  September 14, 2007 ;     700+ words ... ... reduce invasive breast cancer risk in postmenopausal women with osteoporosis INDIANAPOLIS ... breast cancer in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast ...

Article: FDA Advisory Committee Recommends Approval of EVISTA for the ...
PR Newswire;  July 24, 2007 ;     700+ words ... ... provide an important option for postmenopausal women at increased risk for breast cancer ... cancer risk in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer ...

Article: Raloxifene, soy phytoestrogens and endothelial function in ...
Climacteric;  December 1, 2007 ;     700+ words ... ... RALOXIFENE, SOY, PHYTOESTROGENS, POSTMENOPAUSAL WOMEN ABSTRACT Objective To compare the ... endothelial function in healthy, postmenopausal women. Design Randomized, double-blind ... enhanced endothelial function in postmenopausal women. However, the cohort had relatively ...

Article: Dyspareunia in postmenopausal women: A critical ...
Pain Research & Management : The Journal of the Canadian Pain Society;  May 1, 2008 ;     700+ words ... ... Kapuscinski, S Khalif. Dyspareunia in postmenopausal women: A critical review. Pain Res Manage ... problems most frequently reported by postmenopausal women. Past literature has almost unanimously ... suggests that dyspareunia is common in postmenopausal women, and that it is not highly ...

Article: ARZOXIFENE LIFTS BMD IN POSTMENOPAUSAL WOMEN BETTER ...
AsiaPulse News;  March 24, 2009 ;     700+ words ... ... raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis ATHENS, Mar 23 ... Turnover Markers versus Raloxifene in Postmenopausal Women with Osteoporosis Eli Lilly and ... and treatment of osteoporosis in postmenopausal women and the reduction of risk of invasive ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives